Hengrui Pharma Launches IPO, Raising HK$9.7 Billion on Hong Kong Stock Exchange

Jiangsu Hengrui Pharmaceuticals has made a successful debut on the Hong Kong Stock Exchange, raising HK$9.7 billion in an initial public offering (IPO). The company’s listing signifies strong international investor confidence in China’s pharmaceutical sector. A total of 224.5 million shares were sold at HK$44.05 each, exceeding its targeted pricing range and demonstrating high demand from both retail and institutional investors.